SAR218034

an orally nonabsorbable sodium-proton-exchanger subtype 3 inhibitor with antihypertensive and laxative effects; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Greasley, Peter J: 1 article (09/2015)
2.	Spencer, Andrew G: 1 article (09/2015)

1.	Hypertension (High Blood Pressure) 09/01/2015 - "These molecules also reduce blood pressure in rat models of CKD (tenapanor) and hypertension (SAR218034). "

1.	tenapanor